Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

In May, the Centers for Disease Control and Prevention estimated that following a few years of stagnancy, the nation’s HIV transmission rate declined by only 8 percent, to about 34,800 cases ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how ...

For decades, HIV prevention relied on daily pills, but science has made incredible strides. The drug Lenacapavir, originally used for HIV treatment, has been shown to work as PrEP.

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis ...